Endothelin (ET) is considered one of the most potent vasoconstrictor polypeptides; several experimental studies have suggested its possible role in the pathogenesis of arterial vasospasm after subarachnoid haemorrhage (SAH). Previously reported data on plasma and CSF levels of endothelin in patients with a diagnosis of SAH have been controversial. Cisternal endothelin CSF levels and the possibility that they could be related to vasospasm and other clinical patterns of SAH were investigated. CSF samples were obtained from 55 patients admitted after angiographic diagnosis of intracranial aneurysm. Levels of ET-1 and ET-3 were measured through radioimmunoassay technique. 
Abstract
Endothelin (ET) is considered one of the most potent vasoconstrictor polypeptides; several experimental studies have suggested its possible role in the pathogenesis of arterial vasospasm after subarachnoid haemorrhage (SAH). Previously reported data on plasma and CSF levels of endothelin in patients with a diagnosis of SAH have been controversial. Cisternal endothelin CSF levels and the possibility that they could be related to vasospasm and other clinical patterns of SAH were investigated. CSF samples were obtained from 55 patients admitted after angiographic diagnosis of intracranial aneurysm. Levels of ET-1 and ET-3 were measured through radioimmunoassay technique. Twelve patients who had operations for unruptured aneurysms were considered control cases; 43 patients with SAH were classified according to: Hunt and Hess grading at admission, vasospasm grading, CT classification and timing of surgery. In all 55 patients ET-1 was measured, while positive levels of ET-3 were found only in 17 cases of 48. No linear correlation was found between cisternal CSF ET-1 levels when considering time of surgery, CT classification, Hunt Endothelin shows a significant contractile response in cerebral arteries due to a large influx of Ca++ through voltage-dependent C++ channels.2 Much experimental work has been carried out especially on aneurysmal subarachnoid haemorrhage (SAH) and the possible involvement of ET in the pathogenesis of arterial vasospasm.38 Two mechanisms were identified in signal transduction in cerebral arteries.9 The former is specific for ET-1, depends on a specific receptor largely distributed in CNS,'0 and is related to the initial vasoconstrictor effect (calmodulin-dependent mechanism). The latter is common to all three ETs and leads to the characteristic and prolonged vasoconstriction through the activation of a G protein and the protein kinase C." Moreover, ET participates in the enhancement of cellular proliferation in tissues other than vascular endothelium, acting as a local autacoid and activating specific proto-oncogenes.' 12 The endothelial damage due to subarachnoidal blood deposition enhances platelet adhesion and thrombus formation'3 14 and blood clots and plateletdegradation compounds (thrombin, B-TGF) may induce the synthesis of mRNA encoding for ET and the consequent release of the vasoconstrictive peptide.
However, data available from previous studies on ET levels in the CSF and plasma of patients with SAH are controversial regarding the possible relationship with arterial vasospasm occurrence (table 1) . Some authors found a direct correlation between a significant peak in plasma'5 and CSF'6 17 ET-1 levels and the occurrence of symptomatic vasospasm; in other series'8 no correlation was found between CSF ET levels and vasospasm, although a higher plasma ET-1 level at 8-14 days after SAH was found and related to a possible "stress response" in patients showing clinical signs of vasospasm. ' 4 12 30-1 A (fig 3-5) .
ANOVA analysis followed by Student's test and Bonferroni correction showed n statistical differences among subgroupz however, ET-3 levels seem to be slightl higher in cisternal CSF of patients wit higher degree of cisternal clot depositio (CT 3) when compared with CT 1 and CT 2 subgroups; thereafter, the high standard deviation of the data and the relative high level of ET-3 in control cases did not enable us to consider this result definitive. No significant differences were found in ET-3 levels in different subgroups, when only the positive cases were considered. Discussion A considerable amount of experimental work has been published which suggests a possible role for ET-1 in the pathogenesis of arterial vasospasm following aneurysmal SAH. A summary of these data is largely available in 1 recent reviews.'226 ET-1 has a potent con-4 strictor effect on major arteries in vivo in most of the systemic vascular beds, and causes a long-lasting pressor response when injected iv in rats. ET-3 has been shown to have similar effects.2628 As for cerebral vasculature, ET-1, only when injected intracisternally, induced a long-lasting vasoconstrictor effect on the basilar artery of cats,29 in adult mongrel dogs4 and also induced a significant reduction of regional CBF in cats30 and in rats." In rats local CBF was also significantly reduced through topical application of ET-1 .32 When administered into the vertebral artery, ET-1 did not cause any vasoconstrictive effect and was not distributed inside the CNS, except in areas unprotected by the blood-brain barrier.33 Moreover, histological changes shown in the arterial wall after a continuous injection of ET-1 did not significantly 1 differ from degenerative changes observed in 4 spastic basilar arteries of dogs after a double intracisternal injection of arterial blood. 5 Previously reported values of ET-1 and ET-3 CSF levels after aneurysmal SAH in humans vary widely because of the different methods used in CSF sampling. 14 16 26 For example, Fujimori et al'8 did not find any correlation between serial ET levels obtained in CSF collected through a catheter placed in le basal cisterns or in the lateral ventricle, while -1 Kraus et a126 reported higher ET-3 levels in in CSF collected by ventriculostomy in a small ie series (four patients with symptomatic 3s vasospasm). .d
The results of our study suggest that the g-measurements of cisternal CSF ET-3 levels .d should be considered with extreme caution. ig No linear correlation was found between cisternal CSF ET-3 levels, vasospasm grading r-and the Hunt and Hess clinical classification ts at admission. Afterwards, the low percentage ss of positive cases (<20%) and the wide data id range suggest that, after SAH, ET-3 is rarely tn seen and might be considered an epiphenom- Our data for VSP do not agree with thos of other authors'7: however, we considered TCD and angiographical classification of arterial spasm which seems to be a more reliable method than the clinical judgment used in other studies.'7 Conversely, when considering the clinical classification of patients on admission (Hunt and Hess grading system), we observed a slight increase of ET-1 cisternal CSF levels in patients in grades 2 and 3 compared with control cases and to patients with minimal signs (grades 0 and 1). However, no direct correlation was found between ET-1 cisternal CSF level and clinical subgroups (fig 3a) .
Thus the general conclusion from our results is that cisternal CSF levels of ET-1 and -3 are unrelated to vasospasm and to 1 other specific clinical characteristics of 4 aneurysmal SAH; however, some aspects may need emphasis when discussing this lack of correlation. First, a 'normal range' of CSF ET was not available until now because of the different methods used in deproteinisation and of the different characteristics of CSF samples considered.'835 ET does not penetrate through the endothelium and may act only from the adventitial site, as reported in other studies.'229 The CSF sampling from the subarachnoidal cisterns through a direct puncture before the aneurysm exposure and clipping procedure, enabled us to detect a level of ET-1 and ET-3 which was marginally affected by the 'stress response' due to surgical procedures3637 and to avoid questionable interpretations of data obtained through long-1 lasting placement of a cisternal catheter in the subarachnoidal space. 
